Sensitivity of Yeasts to 5-Fluorocytosine

References

1. Davies R. R., Reeves D. S. 1971; 5-Fluorocytosine and urinary candidiasis. Br. Med. J 1:577
   [Google Scholar]
2. Grunberg E., Prince H. N., Utz J. P. 1967; Observations on the activity of two newer anti-fungal agents, saramycetin (X-5079C) and 5-fluorocytosine. Proc. Vth. Internat. Congr. Chemotherapy, Wien 4:69
   [Google Scholar]
3. Holt R. J., Newman R. L. 1972; Urinary candidiasis after renal transplantation. Br. Med. J 2:714
   [Google Scholar]
4. Lodder J. 1970; The yeasts. 2nd ed Amsterdam and London
   [Google Scholar]
5. Louria D. B., Blevins Anne, Armstrong D., Burdick R., Lieberman P. 1967; Fungemia caused by “ nonpathogenic ” yeasts. Archs Intern. Med 119:247
   [Google Scholar]
6. Marks M. I., Eickhoff T. C. 1971; Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob. Agents Chemother 1970 p 491
   [Google Scholar]
7. Marks M. I., Langston Claire, Eickhoff T. C. 1970; Torulopsis glabrata—an opportunistic pathogen in man. New Engl. J. Med 283:1131
   [Google Scholar]
8. Marks M. I., Steer P., Eickhoff T. C. 1971; In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine and clotrimazole (Bay 5097). Appl. Microbiol 22:93
   [Google Scholar]
9. McGill P. E., Sequira R., Jindani A., Nguli E. T., Forrester A. T. T., Fulton W. F. M. 1969; 5-Fluorocytosine in the treatment of cryptococcal meningitis. E. Afr. Med. J 46:663
   [Google Scholar]
10. Record C. O., Skinner J. M., Sleight P., Speller D. C. E. 1971; Candida endocarditis treated with 5-fluorocytosine. Br. Med. J 1:262
    [Google Scholar]
11. Richards A. B., Jones B. R., Whitwell J., Clayton Yvonne M. 1969; Corneal and intra-ocular infection by Candida albicans treated with 5-fluorocytosine. Trans. Ophthal. Soc., U,. K 89:867
    [Google Scholar]
12. Richart R., Dammin G. J. 1960; Candida tropicalis as a pathogen for man. New Engl. J. Med 263:474
    [Google Scholar]
13. Scholer H. J. 1968; Chemotherapie von Mykosen der inneren Organe. Schweiz, med. Wschr 98:602
    [Google Scholar]
14. Scholer H. J. 1970; Antimykoticum 5-fluorocytosin. Mykosen 13:179
    [Google Scholar]
15. Schönebeck J. 1971; 5-Fluorocytosine treatment of candidosis of the urinary tract and Candida infection localised elsewhere. Proc. Congr. Int. Soc. Human and Animal Mycol., Paris p 299
    [Google Scholar]
16. Shadomy S. 1969; In vitro studies with 5-fluorocytosine. Appl. Microbiol 17:871
    [Google Scholar]
17. Shadomy S. 1970; Further in vitro studies with 5-fluorocytosine. Infect. Immun 2:484
    [Google Scholar]
18. Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 1972; 5-Fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann. Intern. Med 76:15
    [Google Scholar]
19. Taschdjian Claire L., Burchall J. J., Kozinn P. J. 1960; Rapid identification of Candida albicans by filamentation on serum and serum substitutes. J. Dis. Child 99:212
    [Google Scholar]
20. Tassel D., Madoff M. A. 1968; Treatment of Candida sepsis and cryptococcus meningitis with 5-fluorocytosine. J. Am. Med. Ass 206:830
    [Google Scholar]
21. Utz J. P. 1972; Flucytosine. New Engl. J. Med 286:777
    [Google Scholar]
22. Utz J. P., Tynes B. S., Shadomy H. J., Duma R. J., Kannan M. M., Mason K. N. 1969; 5-Fluorocytosine in human cryptococcosis. Antimicrob. Agents Chemother 1968 p 344
    [Google Scholar]
23. Webb A. J., Speller D. C. E., Buckler K. G. 1970; Torulopsis glabrata septicaemia treated with 5-fluorocytosine. Lancet 1:839
    [Google Scholar]